+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 6 Actively Recruiting clinical trials

I

Actively Recruiting

Researchers are investigating cavovarus feet deformities, which involve complex changes in multiple planes and present in different forefoot types. The study focuses on adults with Charcot-Marie-Tooth disease, aiming to find a reliable way to identify forefoot morphotypes without using specialized software. This is important because current methods are complex and not easily applied outside specialist centers. Participants will undergo clinical examinations as part of their routine care to assess foot deformities. The study will explore the effectiveness of manual measurements and clinical exams combined with weightbearing CT scans to distinguish between forefoot morphotypes. The research includes both prospective and retrospective elements, examining existing records and new assessments. Participants will be monitored for reproducibility of clinical examination results over 6 months. Data such as clinical findings, imaging, and manual measurements will be collected and analyzed. The study aims to provide practical and reproducible methods for identifying foot deformities in patients with Charcot-Marie-Tooth disease, lasting until the study completion date in late 2027.

Age: 18Years +All Genders
1 location
U

Actively Recruiting

This research aims to improve pelvic rehabilitation for adults with chronic, supra-sacral spinal cord injury SCI by evaluating the use of epidural spinal cord stimulation eSCS combined with pelvic floor muscle training. Up to 20 volunteers will participate, all having confirmed neurogenic detrusor overactivity NDO and responsiveness to dorsal genital nerve stimulation. The study focuses on assessing bladder, bowel, sexual function, quality of life, motor function, and spasticity over time. The study includes two main phases. In Phase I, participants will have a Senza implantable pulse generator placed under the skin, with electrodes positioned to target bladder, bowel, and pelvic floor muscles. Mapping sessions will identify effective stimulation settings for home use. Participants will learn pelvic floor muscle exercises to perform alongside eSCS. Phase II involves a 12-week home trial using these stimulation programs and exercises, with regular clinic visits and weekly phone calls for support and progress review. Participants will undergo extensive assessments including urodynamics, anorectal physiology, bladder and bowel diaries, and various questionnaires before and after the intervention, as well as at 3 and 6 months follow-up. They will be offered the choice to keep or have the eSCS device removed after the trial. Researchers will continue to monitor all participants long-term to evaluate changes in bladder capacity and other key outcomes, ensuring comprehensive safety and effectiveness tracking throughout the study period.

Age: 18Years +All GendersPhase Not Applicable
1 location
I

Actively Recruiting

Researchers are conducting an international, multicenter, prospective observational registry to study patients with X-Linked Hypophosphatemia XLH. This registry aims to collect detailed data on the natural history, treatment patterns, progression, and long-term outcomes of XLH in both adults and children. The study includes patients regardless of whether they are currently receiving treatment for XLH. Participants will be enrolled in a non-interventional setting without any additional treatments or procedures beyond their standard clinical care. Data will be collected retrospectively and prospectively using a web-based system. Physicians will update patient information during routine visits, with reminders to update data approximately every 12 months. Some sites may also participate in a post-authorization safety study PASS to monitor treatment-related adverse events. Participants will provide informed consent or assent according to age and national guidelines. The study team will collect baseline and ongoing clinical information, including treatment details and adverse events, over a period extending to 10 years. No fixed follow-up schedule is required, but data updates align with patients usual healthcare visits. Researchers will review adverse events related to treatment as a primary outcome measure throughout the study period.

All AgesAll Genders
118 locations
G

Actively Recruiting

This research aims to gather real-world data on the outcomes of Boston Scientific neurostimulation systems used for pain management in everyday clinical practice. It focuses on evaluating the long-term effectiveness, economic value, and technical performance of these commercially approved neurostimulation devices when used according to their instructions. Participants will undergo a trial period with a Boston Scientific neurostimulation system for pain. Those who experience positive results from the trial may then receive a permanent implant of the neurostimulation system. The therapy will be personalized based on the investigators judgment and routine site care, following the studys inclusion and exclusion criteria. During the study, participants will be monitored as they receive neurostimulation therapy in real-world settings. Researchers will collect information on treatment outcomes and device performance over time. The study spans from 2012 to 2035, allowing for long-term observation of participants using these neurostimulation systems for pain relief.

Age: 18Years +All Genders
118 locations
S

Actively Recruiting

Knee cartilage injuries can cause pain and limit movement, affecting daily activities like walking and sports. Since cartilage heals poorly on its own, surgery such as autologous chondrocyte implantation ACI is often needed. This study aims to understand how knee function changes after ACI surgery, helping doctors and patients know what to expect and identify issues that physiotherapy might improve. The research is important because untreated cartilage damage can lead to arthritis, a painful condition later in life. Participants in this study will all undergo ACI surgery, which involves two procedures first, harvesting cartilage cells from the patient, then growing these cells in a lab before implanting them to repair the knees damaged cartilage. The study will take place at seven hospitals, with patients invited to attend two appointments at their hospitalone before surgery and one six months afterto assess knee function. During these visits, researchers will measure knee range of motion using a goniometer and analyze walking patterns using motion capture technology. They will also evaluate balance and walking ability. The studys results will provide detailed information about knee movement and function after ACI surgery, which could help improve patient care and treatment outcomes. The entire participation spans about six months with assessments before and after surgery.

Age: 18Years +All Genders
7 locations
E

Actively Recruiting

Researchers are evaluating the efficacy, safety, and tolerability of a drug called INCB000928 in people diagnosed with fibrodysplasia ossificans progressiva FOP, a rare condition. This Phase 2, randomized, double-blind, placebo-controlled trial aims to understand how well INCB000928 works and its pharmacokinetics in different age groups with FOP. The study is sponsored by Incyte Corporation and focuses on treatment outcomes over several years. Participants are divided into three age cohorts 12 years and older, 6 to under 12 years, and 2 to under 12 years after safety review. They receive either INCB000928 or a placebo orally once daily for 24 weeks during the double-blind period. After completing this period, participants may continue in an open-label extension phase lasting an additional 292 weeks, where all receive INCB000928. During the study, participants will undergo low-dose whole-body CT scans excluding the head to monitor new heterotopic ossification lesions. Researchers will measure the number and volume of new lesions and record any new flare-ups. Pharmacokinetics of the drug will be assessed at multiple time points. Safety is closely monitored throughout, including adverse events, with total participation potentially lasting over six years.

Age: 2Years - 99YearsAll GendersPhase 2
24 locations